Involvement of lipid kinase, and signal transduction pathway comprising said lipid kinase, in resistance to HER2-targeting therapy

Details for Australian Patent Application No. 2008239931 (hide)

Owner Stichting Het Nederlands Kanker Instituut

Inventors Bernards, Rene; Berns, Katrien

Agent Freehills

Pub. Number AU-A-2008239931

PCT Pub. Number WO2008/127101

Priority 07106144.4 13.04.07 EP

Filing date 14 April 2008

Wipo publication date 23 October 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

5 November 2009 PCT application entered the National Phase

  PCT publication WO2008/127101 Priority application(s): WO2008/127101

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008239934-Functional serum protein product for use in infant food and therapeutic compositions and methods for the preparation thereof

2008239913-Spar structures